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prescribe AH IA therapy. Data collected: doctors characteristics
and habits regarding HA IA injections use; patients demographic
data and data on their knee OA: level of symptoms, radiolog-
ical grade, other treatments prescribed. Statistics: descriptive:
number (%), mean (SD).
Results: 275 rheumatologists from all areas of France partici-
pated into the study (aged 48 (8) years, 33% women). HA IA
injections use: 20% of RH systematically propose HA injections
to patients. 98% propose in case of a chronically painful knee
OA, 96% to patients who cannot be operated, 86% after anal-
gesics/NSAIDs have failed, 81% in front of an early knee OA.
74% prescribe even if there is a chondrocalcinosis. 67% perform
injections after synovial fluid aspiration and steroids injection.
60% perform HA even in radiologically advanced OA. The choice
of the HA preparation used relies on (by order of citations):
reimbursement (important/very important for 73%), price (70%),
availability (52%), clinical trials performed (50%), HA molecular
weight (33%), preparation concentration (29%), a drug status
(26%). It is mostly considered as a long term treatment (83%),
but some RH use it as a treatment of a flare. Efficacy is as-
sessed on symptoms and scored 60 (14) mm on a VAS by RH.
The overall rate of post-injections side effects estimated by RH
is 5%. Patients description: 523 patients were described, aged
67 (10) years, 65% women, mean weight 75 (13)kg and height
164 (10) cm, mean duration of symptoms 6 (5) years. 97% had
a femoro-tibial knee OA (mostly medial) with a femoro-patellar
OA in 49%. 88% fulfilled the ACR criteria. Mean pain score
on a VAS was 55 (17) mm, 34% had awakenings at night and
74% morning stiffness. 62% had a knee effusion. 75% were
unsuccessfully treated by analgesics/NSAIDs. Most of patients
received analgesics and NSAIDs on the day of visit. 44% were
at a Kellgren-Lawrence grade II and 38% at a grade III. 80% of
patients with a synovial effusion had an aspiration before HA in-
jection. 25% of patients had received a IA steroid injection during
the previous month. 75% were treated by a lateral supra-patellar
approach, 83% were prescribed a 24 hour post-injection rest.
96% of patients were informed of the possibility of a local painful
post-injection reaction. 48% were prescribed an analgesic, 28%
an NSAID, 13% a physical therapy on the same day.
Conclusions: HA IA injections are widely used by RH. 98%
use them frequently, even sometimes as 1st line therapy. Pa-
tients to whom this treatment is prescribed suffer from painful
medial femoro-lateral knee OA, with a high pain level despite
analgesics and/or NSAIDs. The level of reimbursement and
price are the 2 main criteria for choosing the HA preparation
used.This study was financially supported by Expanscience Lab-
oratories (Courbevoie, France)
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Purpose: There are a literature data about possible influence
of some nutrients on the development and progressing of knee
osteoarthritis. It was shown, that the patients with low level
of vitamin C in their blood had a triple progressing risk of
osteoarthritis. Famous properties of vitamins E and A also give a
possibility to think about their role in progressing of osteoarthritis.
The patients with low concentration of vitamin D in feeding
ration have a raised risk of knee osteoarthritis.The purpose of
this study was to determine the relationship of consumption of
different nutrients in feeding ration of postmenopausal women
and incident and stage of knee osteoarthritis.
Methods: Influence of diets on development and progressing
of knee osteoarthritis was investigated in 133 postmenopausal
women. A diagnosis of osteoarthritis was performed along the
criteria of American rheumatology association (1995), its stage -
by Kiellgren-Lourenz classification.
Results: We did not found the differences in contents of most
macro- and micronutrients in depend of incident and stage of
osteoarthritis, however it was a tendency in consumption of
some microelements and vitamins. The patients with OA com-
pared with control group have a more level of β-carotin (F=2,64,
p=0,11), folacin (F=2,94, p=0,09), less level of vitamin D (ac-
cordingly 0,33±0,04 and 0,53±0,06; F=6,51, p=0,01). We have
not founded the differences in consumption of vitamin C (F=1,96,
p=0,16), vitamin A (F=0,05, p=0,83) and E (F=0,85, p=0,36) in
patients dependency on presence of arthritis. The tertiles analy-
sis showed that frequency of knee osteoarthritis in women in first
tertile was 48,9%, fourth tertile - 22,7%. We have not founded
the differences in consumption of all macro- and micronutrients
in depend of stage
Conclusions: Our results shows that in the feeding ration of
postmenopausal women with gonarthritis there are significant
more level of vitamin D and diminished level of some microele-
ments and vitamins, that can contribute to its progressing.
Genetics and Genomics
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Purpose: Our study aimed to investigate the contribution of leptin
to the pathophysiology of osteoarthritis (OA), a common degen-
erative joint disease, and explore leptin’s effect on chondrocytes
cultures.
Methods: Articular cartilage samples were obtained from femoral
heads, femoral condyles and tibial plateaus of patients with pri-
mary OA undergoing hip or knee replacement surgery at the
Orthopaedics Department of University Hospital of Larissa. A
total of 15 patients were included in the study. RNA was isolated
using Trizol reagent and was further purified. mRNA expression
levels of leptin and Ob-Rb were measured by real-time quantita-
tive RT-PCR (Light Cycler Instrument, Roche Molecular Systems,
Alameda, CA).
Primary chondrocytes cultures, normal and osteoarthritic, were
stimulated with leptin (0-100ng/mL) and cell proliferation as well
as leptin-induced IL-1β production were measured, by the use of
an MTT assay and a commercially available ELISA kit respec-
tively. Serum and SF leptin concentrations were also measured
with ELISA technique.
Results: An intrajoint differential expression of leptin and Ob-Rb
mRNA was observed between advanced and mild OA cartilage;
a statistically significant increase in leptin mRNA expression
was observed from the mild (0.066 ± 0.069 leptin copies/PBGD
copies) to the severely (0.21 ± 0.095 leptin copies/PBGD copies)
damaged OA cartilage (t(13)=6.265, p<0.001). When matched
paired analysis of the samples was performed, a statistically
significant increase in Ob-Rb mRNA was observed from the mild
(0.018 ± 0.031 Ob-Rb copies/PBGD copies) to severe dam-
aged OA cartilage (0.194 ± 0.178 Ob-Rb copies/PBGD copies).
We also observed significantly higher mean leptin mRNA ex-
pression in obese patients (0.294 ± 0.039 leptin copies/PBGD
copies) compared to normal weight patients (0.1 ± 0.02 lep-
tin copies/PBGD copies). Leptin’s mRNA expression levels in
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advanced OA cartilage correlated significantly with BMI values
of the patients (r=0.610, p<0.05). SF had higher leptin con-
centrations than the paired serum sample, while a significant
correlation was observed between serum and SF leptin levels
(r=0.672, p<0.01). In normal chondrocytes cultures (48 hrs),
leptin enhanced cell proliferation but reduced it in osteoarthritic
chondrocytes, while in long term cultures leptin had a similar
detrimental effect on chondrocytes. Furthermore, leptin induced
the production of IL-1β in long term cultures.
Conclusions: For the first time to our knowledge, using quan-
titative real-time PCR, we observed leptin and Ob-Rb mRNA
expression in chondrocytes of osteoarthritic cartilage. The ob-
served intrajoint difference in leptin and Ob-Rb mRNA expres-
sion between advanced and minimally affected knee and hip
osteoarthritic cartilage, along with the higher observed leptin
concentrations in SF than in paired serum samples indicate a
local role of leptin in joint tissues. The increased leptin’s mRNA
expression in obese compared to normal weight patients sug-
gested that mechanical overload may alter chondrocytes’ phe-
notype. Also the decrease in chondrocyte’s proliferation after
induction with leptin points toward a long term detrimental ef-
fect on cartilage, while the observed IL-1β production suggests
an inflammatory role of leptin, which may account for cartilage
degradation. Taken together our findings support the hypothesis
that leptin is involved in OA development and that may be the
missing link between biomechanical and metabolic factors in-
volved in OA. However, further studies are needed to confirm the
involvement of leptin in OA and to investigate the link between
obesity, inflammation, leptin and osteoarthritis.
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Purpose: The matrix metalloproteinase (MMP) family consists
of 23 structurally related proteases that are able to degrade a
wide range of substrates, including many components of the ex-
tracellular matrix (ECM). MMP-28 (epilysin), is a recently cloned
member of the MMP family. We have recently described MMP28
expression in cartilage with significant increase in osteoarthri-
tis. The principle level of control of MMP expression is gene
transcription. The promoter region of both human and mouse
MMP28 has been cloned and characterised. Conserved mo-
tifs were identified that could control the expression of MMP28
including a GT-box situated 300 bp upstream from the trans-
lation start site that binds both Sp1 and Sp3 proteins and
is essential for MMP28 basal expression in keratinocytes. We
showed recently that histone deacetylase inhibitors (HDACi) are
chondroprotective. Whilst HDACi downregulate expression of a
number of MMPs, a small subset are induced and this includes
MMP28.
Methods: Promoter-reporter constructs were made in pGL3 and
transiently transfected into HeLa or SW1353 cells using Fu-
Gene6. DNA-protein interaction was assessed by gel mobility
shift assay. Acetylation of Sp1 and Sp3 was probed using im-
munoprecipitation with a specific antibody and Western blotting
with an anti-(pan acetyl lysine) antibody.
Results: Transient transfection assays with deletion constructs
of the MMP28 gene promoter, showed that HDACi, including
trichostatin A (TSA), valproic acid, sodium butyrate, upregulate
transcription from the promoter via the promoter proximal GT
described above. This was confirmed using point mutants in this
site. Gel mobility shift and supershift assays using Sp1/2/3 anti-
bodies showed that Sp1 and Sp3 bind to the MMP28 promoter
via the GT-box. Using transient transfection assays with the wild
type and mutant promoters we showed that Sp1, but not Sp3,
can induce the MMP28 promoter via the GT-box. HDACi induce
transcription from the promoter via Sp1 action at this site. Sp1 is
known to interact with the histone acetyltransferase (HAT) p300
and histone deacetylase 1 (HDAC1). Forced overexpression of
either p300 or PCAF, but not CBP (all of which are known HATs),
induces the MMP28 promoter, as does siRNA knockdown of
HDAC1. Sp1 and 3 can both be acetylated and phosphory-
lated which is reported to alter their DNA-binding properties.
In immunoprecipitation experiments, the acetylation of Sp1 and
Sp3 was increased by TSA treatment. Furthermore, the ser-
ine/threonine phosphatase inhibitor, okadaic acid can block the
TSA induction of the MMP28 promoter. Oligo pulldown experi-
ments have identified a 37kD protein which specifically interacts
with the GT-box, and this is currently being identified using mass
spectrometry.
Conclusions: These results suggest that acetylation regulates
the MMP28 gene via a promoter proximal GT-box which directly
binds and is activated by Sp1. Other proteins are also involved
in mediating the induction of MMP28, including at least p300,
PCAF, HDAC1 and a currently unidentified 37kD protein.
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Purpose: We recently identified RHOB as a gene over-
expressed in OA patients. The analysis of RHOB expression
revealed allelic imbalances indicating cis-regulatory mechanisms
and indeed, a single nucleotide polymorphism (SNP) at -165
in the RHOB promoter turned out to be associated with OA.
We here investigate in detail the regulation of RHOB expres-
sion and the functional consequences of its over-expression in a
chondrosarcoma line.
Methods: Apoptosis following over-expression of RHOB in the
human chondrosarcoma line SW1353 was assayed via quantifi-
cation of cells in the sub-G1 phase of the cell cycle and con-
firmed by confocal laser microscopy. Disease association of the
variable number of tandem repeats (VNTR) polymorphism was
determined by PCR. Luziferase assays in combination with re-
porter constructs were performed to measure the various RHOB
promoter activities.
Results: The RHOB genotyping data support a recessive model
for the SNP at -165 with the homozygous genotype (G/G) con-
ferring an Odds ratio of 4.3 to develop OA. An additional VNTR
polymorphism in the promoter region shows a distinct linkage
disequilibrium (LD) with the -165 SNP whereby in the controls
the T-allele is preferentially linked to 13 tandem repeats. In con-
trast, 10 tandem repeats are preferentially linked to the G-allele in
the patients. The corresponding p values indicating the linkages
are 0.0009 and 0.0144, respectively. The SubG1-assays reveal a
7-fold higher apoptosis rate of RHOB over-expressing cells com-
pared to cells expressing the normal endogenous levels. This
increase in cells entering the sub-G1 phase is paralleled by an
apoptotic phenotype of cell shrinking and flaking.
Conclusions: Our results support the concept of OA being
the consequence of active disease processes. We show that
